Sarepta Therapeutics, Inc. (SRPT) Description, Stock price, News & Info.

#ThinkSabio Latest News

Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYS